Cognitive impairment in relation to depression, anxiety and virological response in hepatitis C patients in Egypt

References

• Abrantes J, Torres DS, de Mello CE. 2013. Patients with hepatitis C infection and normal liver function: an evaluation of cognitive function. Postgrad Med J 89:433–439.
   PubMed Web of Science ®Google Scholar
• Abu Faddan NH, Shehata GA, Abd Elhafeez HA, Mohamed AO, Hassan HS, Abd El Sameea F. 2014. Cognitive function and endogenous cytokine levels in children with chronic hepatitis C. J Viral Hepat doi: 10.1111/jvh.12373.
   PubMed Web of Science ®Google Scholar
• Adair DM, Radkowski M, Jablonska J, Pawelczyk A, Wilkinson J, Rakela J, Laskus T. 2005. Differential display analysis of gene expression in brains from hepatitis C-infected patients. AIDS 19:145–150.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (APA). 2000. Diagnostic and Statistical Manual of Mental Disorders. 4th edition, text-revision, American Psychiatric Association.
   Google Scholar
• Back-Madruga C, Fontana R, Bieliauskas LA, Burton-Williams M, Wright E, Padmanabhan L, et al. 2003. Predictors of cognitive impairment in chronic hepatitis C patients entering the HALT-C trial (Abstract). J Int Neuropsychol Soc 9:245.
   Google Scholar
• Bieliauskas LA, Back-Madruga C, Lindsay KL. 2006. Clinical relevance of cognitive scores in hepatitis C patients with advanced fibrosis. J Clin Exp Neuropsychol 28:1346–1361.
   PubMed Web of Science ®Google Scholar
• Blass JP. 2001. Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia? J Neurosci Res 66:851–856.
   PubMed Web of Science ®Google Scholar
• Byrnes V, Miller A, Lowry D, Hill E, Weinstein C, Alsop A, et al. 2011. Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition. J Hepatol 56:37–44
   Google Scholar
• Capuron L, Pagnoni G, Demetrashvili M, Woolwine BJ, Nemeroff CB, Berns GS, et al. 2005. Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry 58:190–196.
   PubMed Web of Science ®Google Scholar
• Capuron L, Dantzer R, Miller AH. 2003. Neuro-immune interactions in psychopathology with the example of interferon-alpha-induced depression. J Soc Biol 197:151–156.
   PubMedGoogle Scholar
• Cattie JE, Letendre SL, Woods SP, Barakat F, Perry W, Cherner M, et al. 2014. Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment. J Neurovirol 20:561–570.
   PubMed Web of Science ®Google Scholar
• Chiu WC, Tsan YT, Tsai SL, Chang CJ, Wang JD, Chen PC, et al. 2014. Hepatitis C viral infection and the risk of dementia. Eur J Neurol 21:1068–e59.
   PubMed Web of Science ®Google Scholar
• Cordoba J, Flavia M, Jacas C, Sauleda S, Esteban JI, Vargas V. 2003. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 39:231–238.
   PubMed Web of Science ®Google Scholar
• Costa AS, Fimm B, Friesen P, Soundjock H, Rottschy C, Gross T, et al. 2012. Alternate-form reliability of the Montreal cognitive assessment screening test in a clinical setting. Dementia Geriatr Cogn 33:379–384.
   PubMed Web of Science ®Google Scholar
• Dróżdż W, Borkowska A, Halota W, Rybakowski JK. 2008. Depressive symptoms and cognitive dysfunction in patients with hepatitis C treated with interferon-α and ribavirine. Arch Psychiatr Psychother 1:85–91.
   Google Scholar
• El Sayed H, El Sayed M, Arafa M, Elbendary M. 2012. Prospective study of psychiatric side effects during antiviral therapy of chronic hepatitis C in an Egyptian sample. Middle East Curr Psychiatry 19:71–77.
   Google Scholar
• Fontana R, Bieliauskas L, Lindsay K, Madruga C, Wright E, Snow K, et al. 2007. Cognitive Function Does Not Worsen During Pegylated Interferon and Ribavirin Retreatment of Chronic Hepatitis C. Hepatology 45:1154–1163.
   PubMed Web of Science ®Google Scholar
• Fontana RJ, Bieliauskas LA, Back-Madruga C, Lindsay KL, Kronfol Z, Lok AS, et al. 2005. Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol 43:614–622.
   PubMed Web of Science ®Google Scholar
• Forton DM, Hamilton G, Allsop JM, Grover VP, Wesnes K, O’Sullivan C. 2008. Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study. J Hepatol 49:316–322.
   PubMed Web of Science ®Google Scholar
• Forton DM, Taylor-Robinson SD, Thomas HC. 2006. Central nervous system changes in hepatitis C virus infection. Eur J Gastroenterol Hepatol 18:333–338.
   PubMed Web of Science ®Google Scholar
• Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, et al. 2002. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 35:433–439.
   PubMed Web of Science ®Google Scholar
• Freitas S, Simoes MR, Alves L, Santana I. 2012. Montreal Cognitive Assessment: Influence of Sociodemographic and Health Variables. Arch Clin Neuropsychol 27:165–175.
   PubMed Web of Science ®Google Scholar
• Gong G, Waris G, Tanveer R, Siddiqui A. 2001. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci 98:9599–9604.
   PubMed Web of Science ®Google Scholar
• Grover VP, Pavese N, Koh SB, Wylezinska M, Saxby BK, Gerhard A, et al. 2012. Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J Viral Hepat 19:e89–96.
   PubMed Web of Science ®Google Scholar
• Gualtieri CT, Johnson LG, Benedict KB. 2006. Neurocognition in depression: patients on and off medication versus healthy comparison subjects. J Neuropsychiatry Clin Neurosci 18:217–225.
   PubMed Web of Science ®Google Scholar
• Hermann C. 1997. International experiences with the hospital anxiety and depression scale—a review of validation data and clinical results. J Psychosomatic Res 42:17–41.
   PubMed Web of Science ®Google Scholar
• Hilsabeck R, Anstead G, Webb A, Hoyumpa A, Ingmundson P, Holliday S, et al. 2010. Cognitive efficiency is associated with endogenous cytokine levels in patients with chronic hepatitis C. J Neuroimmunol 221:53–61.
   PubMed Web of Science ®Google Scholar
• Hilsabeck RC, Hassanein TI, Ziegler EA, Carlson MD, Perry W. 2005. Effect of interferon- alpha on cognitive functioning in patients with chronic hepatitis C. J Int Neuropsychol Soc 11:16–22.
   PubMed Web of Science ®Google Scholar
• Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. 2003. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc 9:847–854.
   PubMed Web of Science ®Google Scholar
• Hilsabeck RC, Perry W, Hassanein TI. 2002. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 35:440–446.
   PubMed Web of Science ®Google Scholar
• Huckans M, Seelye A, Parcel T. 2009. The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. J Int Neuropsychol Soc 15:69–82.
   PubMed Web of Science ®Google Scholar
• Juengling FD, Ebert D, Gut O, Engelbrecht MA, Rasenack J, Nitzsche EU, et al. 2000. Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology 152:383–389.
   PubMed Web of Science ®Google Scholar
• Karaivazoglou K, Assimakopoulos K, Thomopoulos K, Theocharis G, Messinis L, Sakellaropoulos G, et al. 2007. Neuropsychological function in Greek patients with chronic hepatitis C. Liver Int 27:798–805.
   PubMed Web of Science ®Google Scholar
• Kramer L, Bauer E, Funk G, Hofer H, Jessner W, Steindl-Munda P, et al. 2002. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 37:349–354.
   PubMed Web of Science ®Google Scholar
• Kraus MR, Schafer A, Wissmann S, Reimer P, Scheurlen M. 2005. Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin. Clin Pharmacol Ther 77:90–100.
   PubMed Web of Science ®Google Scholar
• Lee BN, Dantzer R, Langley KE, Bennett GJ, Dougherty PM, Dunn AJ, et al. 2004. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11:279–292.
   PubMed Web of Science ®Google Scholar
• Letendre S, Paulino AD, Rockenstein E. 2007. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis 196:361–370.
   PubMed Web of Science ®Google Scholar
• Lieb K, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Janssen G, et al. 2006. Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFN a): results from a prospective study. Eur Psychiatry 21:204–210.
   PubMed Web of Science ®Google Scholar
• Lucchese G, Kanduc D. 2014. Single amino acid repeats connect viruses to neurodegeneration. Curr Drug Discov Technol 11:214–219.
   PubMedGoogle Scholar
• MacParland SA, Pham TN, Guy CS, Michalak TI. 2009. Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro. Hepatology 49:1431–1434.
   PubMed Web of Science ®Google Scholar
• Majer M, Welberg L, Capuron L, Pagnonia G, Raison C, Miller A. 2008. IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain Behav Immun 22:870–880.
   PubMed Web of Science ®Google Scholar
• Martin CR. 2005. What does the hospital anxiety and depression scale (HADS) really measures in liaison psychiatry settings? Curr Psych Rev 1:69–73.
   Google Scholar
• Matthews SC, Paulus MP, Dimsdale JE. 2004. Contribution of functional neuroimaging to understanding neuropsychiatric side effects of interferon in hepatitis C. Psychosomatics 45:281–286.
   PubMed Web of Science ®Google Scholar
• McAndrews MP, Farcnik K, Carlen P, Damyanovich A, Mrkonjic M, Jones S, Heathcote EJ. 2005. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 41:801–808.
   PubMed Web of Science ®Google Scholar
• Meguid M, Moussa M. 2010. Cognitive Function in Hepatitis C Patients: Effect of Pegylated Interferon α and Ribavirin Therapy. Curr Psychiatry 17:45–51.
   Google Scholar
• Mendoza-Fernandez V, Andrew RD, Barajus-Lopez C. 2000. Interferon-α inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus. Brain Res 885:14–24.
   PubMed Web of Science ®Google Scholar
• Meyers CA, Albitar M, Estey E. 2005. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104:788–793.
   PubMed Web of Science ®Google Scholar
• Michopoulos I, Douzenis A, Kalkavoura C, Christodoulou C, Michalopolou P, Kalemi G, et al. 2008. Hospital anxiety and depression scale (HADS): validation in Greek general hospital sample. Ann Gen Psychiatry 7:1–5.
   PubMedGoogle Scholar
• Monaco S, Ferrari S, Gaiofatto A, Zanusso G, Marriotto S. 2012. HCV-related nervous system disorders. Clin Dev Immunol 2012:236148.
   PubMed Web of Science ®Google Scholar
• Narazaki K, Nofuji Y, Honda T, Matsuo E, Yonemoto K, Kumagai S. 2013. Normative data for the Montreal cognitive assessment in a Japanese community-dwelling older population. Neuroepidemiology 40:23–29.
   PubMed Web of Science ®Google Scholar
• Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. 2005. The Montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriat Soc 53:695–699.
   PubMed Web of Science ®Google Scholar
• Nassef AM, Zaki-El-Din H, Abdel-Sameia AM, Barakat EM, Genidi E, Hamdi K. 2008. Cognitive dysfunction in patients with chronic hepatitis C. Egypt J Neurol Psychiatr Neurosurg 45:251–267.
   Google Scholar
• Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, et al. 2002. Mitochondrial injury, oxidative stress, and anti-oxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122:366–375.
   PubMed Web of Science ®Google Scholar
• Pasi M, Salvadori E, Poggesi A, Inzitari D, Pantoni L. 2013. Factors predicting the Montreal Cognitive Assessment (MOCA) applicability and performances in a stroke unit. J neurol 260:1518–1526.
   PubMed Web of Science ®Google Scholar
• Pattullo V, McAndrews MP, Damyanovich A, Heathcote E. 2011. Infuence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes. Liver Int 31:1028–1038.
   PubMed Web of Science ®Google Scholar
• Pawelczyk T, Pawelczyk A, Strzelecki D, Jablonska J. 2008. Pegylated interferonα and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients. Gen Hosp Psychiat 30:501–508.
   PubMed Web of Science ®Google Scholar
• Perry W, Hilsabeck RC, Hassanein TI. 2008. Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci 53:307–321.
   PubMed Web of Science ®Google Scholar
• Pfennig A, Littmann E, Bauer M. 2007. Neurocognitive impairment and dementia in mood disorders. J Neuropsychiatry Clin Neurosci 19:373–382.
   PubMed Web of Science ®Google Scholar
• Pham TN, Michalak TI. 2008. Hepatitis C virus in peripheral blood mononuclear cells of individuals with isolated anti-hepatitis C virus antibody reactivity. Hepatology 48:350–351.
   PubMed Web of Science ®Google Scholar
• Porter RJ, Bourke C, Gallagher P. 2007. Neuropsychological impairment in major depression: Its nature, origin and clinical significance. The Australian and New Zealand Journal of Psychiatry 41:115–128.
   PubMed Web of Science ®Google Scholar
• Posada CBA, Morgan E, Moore D, Woods S, Psy D, Letendre S, et al . 2009. Neurocognitive Effects of the Hepatitis C Virus. Current Hepatitis Reports 8:158–166.
   Google Scholar
• Posner MI, Fan J. 2005. Attention as an organ system. In: Pomerantz J, editor. Neurobiology of perception and communication: from synapse to society. The IVth De Lange Conference, Cambridge UK: Cambridge University Press.
   Google Scholar
• Radkowski M, Gallegos-Orozco JF, Jablonska J. 2005. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41:106–114.
   PubMed Web of Science ®Google Scholar
• Rahman TA, El Gaafary MM. 2009. Montreal cognitive assessment Arabic version: reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. Geriatr Gerontol Int 9:54–61.
   PubMed Web of Science ®Google Scholar
• Reichenberg A, Gorman JM, Dieterich DT. 2005. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study. AIDS 19:174–178.
   PubMed Web of Science ®Google Scholar
• Ryan EL, Morgello S, Isaacs K, Phil M, Naseer M, Gerits P, et al. 2004. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 62:957–962.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Sarkar R, Berg T, Schaefer M. 2015. Sadness and mild cognitive impairment as predictors for interferon-alpha-induced depression in patients with hepatitis C. Br J Psychiatry 206:45–51.
   PubMed Web of Science ®Google Scholar
• Sas AR, Bimonte-Nelson HA, Tyor WR. 2007. H.I.V. Cognitive dysfunction in S.C.I.D. encephalitic mice correlates with levels of Interferon-alpha in the brain. AIDS 21:2151–2159.
   PubMed Web of Science ®Google Scholar
• Schaefer M, Capuron L, Friebe A, Diez-Quevedo C, Robaeys G, Neri S, et al. 2012. Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement. J Hepatol 57:1379–1390.
   PubMed Web of Science ®Google Scholar
• Schwer B, Ren S, Pietschmann T, Kartenbeck J, Kaehlcke K, Bartenschlager R. 2004. Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J Virol 78:7958–7968.
   PubMed Web of Science ®Google Scholar
• Senzolo M, Schiff S, D’Aloiso CM. 2011. Neuropsychological alterations in hepatitis C infection: the role of inflammation. World J Gastroenterol 17:3369–3374.
   PubMed Web of Science ®Google Scholar
• Smith T, Gildeh N, Holmes C. 2007. The Montreal cognitive assessment: Validity and utility in a memory clinic setting. Can J Psychiatry 52:329–332.
   PubMed Web of Science ®Google Scholar
• SPSS for Windows. 2001. Statistical package for the social sciences. Version 11.0.1. Chicago: SPSS Inc.
   Google Scholar
• Vigil O, Posada C, Woods SP. 2008. Impairments in fine-motor coordination and speed of information processing predict declines in everyday functioning in hepatitis C infection. J Clin Exp Neuropsychol 27:1–11.
   Google Scholar
• Vivithanaporn P, Maingat F, Lin LT. 2010. Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicity. PLoS One 5:128–156.
   Web of Science ®Google Scholar
• Weissenborn K, Krause J, Bokemeyer M. 2006. Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut 55: 1624–1630.
   PubMed Web of Science ®Google Scholar
• Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schuler A, Ennen JC, et al. 2004. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 41:845–851.
   PubMed Web of Science ®Google Scholar
• Wilkinson J, Radkowski M, Laskus T. 2009. Hepatitis C virus neuroinvasion: identification of infected cells. J Virol 83:1312–1319.
   PubMed Web of Science ®Google Scholar
• Williams K, Alvarez X, Lackner AA. 2001. Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia 36:156–164.
   Google Scholar
• Wobrock T, Mihm U, Löhr C, Hofmann WP, Sarrazin C, Zeuzem S. 2009. Cognition in hepatitis C patients treated with pegylated interferon. World J Biol Psychiatry 10:819–826.
   PubMed Web of Science ®Google Scholar
• Zalai D, Sherman M, McShane K, Shapiro CM, Carney CE. 2015. The importance of fatigue cognitions in chronic hepatitis C infection. J Psychosom Res 78:193–198.
   PubMed Web of Science ®Google Scholar
• Zheng L, Teng EL, Varma R, Mack WJ, Mungas D, Lu PH, et al. 2012. Chinese-Language Montreal Cognitive Assessment for Cantonese or Mandarin Speakers: Age, Education, and Gender Effects. Int J Alzheimer's Dis 23:1–10.
   Google Scholar
• Zigmond AS, Snaith RP. 1983. The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370.
   PubMed Web of Science ®Google Scholar